Navigation Links
Daniel E. Crookshank Joins Mylan as Vice President - Investor Relations

PITTSBURGH, July 21 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) announced today the appointment of Daniel E. Crookshank as vice president - Investor Relations and as a member of the company's senior leadership team. Reporting to Chief Financial Officer Edward J. Borkowski, Crookshank is responsible for all investment community communication as well as for the development and direction of activities that proactively promote Mylan to the investment community.

"Dan has a well-deserved reputation as an outstanding, senior investor relations professional," said Mylan Vice Chairman and CEO Robert J. Coury. "His extensive international experience - together with his comprehensive knowledge of finance and solid accounting background - will serve the company well going forward. We're excited to have an individual with Dan's talents joining our Mylan team."

Crookshank served most recently as vice president - Investor Relations for Rockwell Collins, a global manufacturer of communications and aviation electronics solutions for commercial and military customers worldwide. During his 18-year career with Rockwell Collins and Rockwell International, he served in a number of increasingly responsible positions within Finance. Crookshank also completed accounting assignments with National Steel Corporation and H.J. Heinz Corporation. He began his business career with the public accounting firm Deloitte, Haskins & Sells, now Deloitte & Touche.

Crookshank earned a bachelor's degree in business administration from Robert Morris University and an MBA from the Katz Graduate School of Business at the University of Pittsburgh.

Mylan Inc., with operations in more than 90 countries, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's second largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies.

SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dr. Daniel Von Hoff Discusses "The Complete Phase Ib," A Clinical Trial Design Offering Faster Drug Development, Economies of Scale and Improved Therapeutic Benefit
2. MaxLife Fund Corp. Appoints Mr. Dan Schmitt, Mr. Randy Delkus and Mr. Daniel E. Kahan to its Board of Directors
3. Daniel Corcoran named President of Anthem Blue Cross and Blue Shield in Maine
4. HealthSouth Finalizes Sale of Corporate Campus to Daniel Corporation
5. Hiemstra Appoints Daniel C. Rosenman as Vice President of Research & Development
6. Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research
7. Statement by Daniel W. Jones, M.D., American Heart Association President on President Bushs FY 2009 Budget Proposal
8. Vincent Corso and Daniel Trush Win 2007 Avis We Try Harder Awards
9. MaxLife Fund Corp. appoints Daniel E. Kahan, to its Advisory Board
10. Global Health Trax Joins Fight Against Autism With Jenny McCarthy and Generation Rescue
11. Bernadette Peters Joins Board of Directors of Standing Tall, Innovative Program for Multiply Disabled Children
Post Your Comments:
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the Los ... article to the newly revamped Cosmetic Town journal section, featuring articles ... procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi says ...
(Date:10/12/2017)... RAPIDS, Mich. (PRWEB) , ... October 12, 2017 ... ... Wellness, has been named one of Michigan’s 2017 Best and Brightest in Wellness® ... and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017 Halo Labs announces the European launch of their ... HORIZON at MIBio 2017 in Cambridge, U.K ... matter in biopharmaceutical samples with unprecedented speed and sensitivity while using ... Backgrounded Membrane Imaging. ... subvisible particle analysis system ...
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... that its MyDario product is expected to appear on The Dr. Oz ... Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The Dr. Oz Show kicked ... The segment features ...
(Date:9/22/2017)... SAN DIEGO , Sept. 22, 2017 ... ll medical device is now successfully helping those with ... Union. Fibromyalgia diagnosed Amanda in ... getting dressed and washing my hair, experiencing no sleep ... body in painful spasm… I cannot recommend [the AVACEN ...
Breaking Medicine Technology: